Changing pattern of in-stent restenosis after intracoronary beta-irradiation: downsizing the lesion  by Naber, Christoph K. et al.
22A ABSTRACT6 - ACCIS2002 (Angiography & Interventional Cardiology) JACC March 6,2002 
0032-6 impact of Clinical Syndrome Acuity on the Differential 
Response to Two Glycoproteln iib/iiia inhibitors in 
Patients Undergoing Coronary Stenting: The TARGET 
Trial 
VW. David J. Moliterno, Michel Bertrand, Franz-Joseph Neumann, Howard 
C. Herrmann, Eric R. Powers, Cindy L. Grines. David J. Cohen, Eric A. Cohen, Marc 
Cohen, Marion Piedmonte, Pete M. DiBattiste, The Cardiovascular Research 
Foundation, New York, New York, Lenox Hill Heart and Vascular Institute, New York, 
New York. 
Background. GP Ilb/llla inhibitors reduce per&procedural events and enhance out- 
comes in pts undergoing stent implantation. The relative safety and efficacy of different 
Ilb/llta agents is less wall established. Also unknown is whether the acuity of the present- 
ing clinical syndrome, which may affect the degree of platelet inhibition required or 
achieved, influences the response to different anti-platelet agents. Methods. In the TAR- 
GET trfal, 4,609 pts undergoing stenting were randomized to abciximab vs. timfiban in 
double blind fashion. Acute coronary syndromes (unstable angina or Ml) were present in 
3,025 pts (63%) and non ACS were present in 1,764 pts (37%). 
Results. The 30-day composite incidence of death, Ml or urgent TVR occurred in 6.0% 
of pts assigned to abciximab vs. 7.6% assigned to tirofiban (p&036). By 6 months 
death, MI or any TVR occurred in 14.3% vs. 14.6% of pts respectively (pzO.59). Out- 
cornea stratified by clinical syndrome appear In the table: 
Conclusions. In pts with ACS undergoing stent implantation, abciximab use compared 
to tirofiban results in lower 30 day and 6 month rates of MI, though survival is identical. In 
contrast, pts with stable coronary syndromes treated with tirofiban have excellent acute 
and late outcomes relative to ab=cirimab. These data raise important issues regarding the 
relative pharmacodynamic potency of Ilb/llla inhibition required in varying clinical scenar- 
ios, as well as having important implications for cost-effective utilization of Ilb/llla inhibi- 
tors. 
ACS Non ACS 
Abciximab Tirofiban P Abciximab Tirofiban P 
N 1,511 1,514 - 900 604 . 
Procedural success (%) 96.2 96.0 NS 96.9 96.0 NS 
Bleeding complications (%) 4.7 3.4 NS 5.1 4.0 NS 
RBC transfusion (%) 1.6 1.1 NS 1.3 1.0 NS 
Thrombccytopenia (%) 3.6 0.6 co.oo1 3.4 0.3 co.oo1 
30 day: Death (%) 0.6 0.6 NS 0.1 0.3 NS 
Ml (%) 5.6 6.5 0.004 4.9 4.2 NS 
Urgent TVR (%) 0.5 1.1 0.10 0.9 0.5 NS 
Composite (%) 6.3 9.3 0.002 5.6 4.5 NS 
6 month: Death(%) 1.3 1.3 NS 0.6 0.7 NS 
Ml (%) 7.1 9.6 0.01 5.6 5.1 NS 
Any TVR(%) 9.0 9.5 NS 6.0 5.7 NS 
Composite (%) 15.1 17.6 0.06 13.0 10.2 0.07 
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1077-I Ostlai Location of Target Lesion and Smaller Post- 
Treatment Minimal Luminai Diameter Are Predictors of 
Failure Following Sr-90 Beta Irradiation for instent 
Restenosis 
Francis 0. Alme&. David Y. Chua, Sandeep Nathan, Susie Kim, Peter M. Meyer, 
Stephen T. Thew, Jeffrey Snell, Gary L. Schaer. Rush-Presbyterian-St. Luke’s Medical 
Center, Chicago, Illinois. 
Background: lntracoronary radiation therapy (IRT) with Sr-90 has been shown to be 
effective for the treatment of instent restenosis (ISR) compared to placebo in large ran- 
domized clinical trials. However, the predictors of failure following IRT in a broad range of 
patients (pts) have not been clearly defined. 
Methods: To determine the predictors of IRT failure, we compared the baseline demo- 
graphics, lesion characteristics, and clinical outcomes of 102 consecutive pts with ISR 
treated with Sr-90 using the Novosta Beta-Cath System from Sept.1996 to July 2001. 
IRT failure was defined as death, myocardial infraction (MI), or target vessel revascular- 
ization (TVR) due to repeat ISR on follow up. 
Results: A comparison of the clinical and angiographic profile of IRT failures vs. suc- 
cesses is shown using univariate analysis (Table). Multivariate regression analysis 
showed that the predictors of failure that remained significant were treatment of an ostial 
lesion (OR 31.2, 95% Cl 2.6, 362.7, p=O.O07), and post-treatment MLD (p<O.OOl). 
Table: PredIctora of IRT Failure Uslng Unlvariate Analysis 
IRT Failure IRT Success P value 
(n.16) (n=66) 
Mean Age (yrs) 61.5+11.1 61.6zt12.4 0.704 
Male % 69 79 0.521 
Diabetes % 77 65 0.766 
Hypertension % 100 91 0.351 
Hyperlipidemia 94 93 0.916 
Smoking Hx % 75 40 0.012 
Family History of CAD % 43 35 0.367 
Prior CABG % 50 43 0.765 
Calcium Channel Blocker Use % 64 45 0.013 
SVG Lesion % 19 14 0.701 
Ostial Lesion % 44 16 0.020’ 
Mean Lesion Length (mm) 17.67fl2.2 17.27+12.5 0.324 
Mean Reference Vessel Diameter (mm) 2.96zt0.35 3.14ti.91 0.567 
Mean Pre-Treatment MLD (mm) o.tio.14 1.010.19 0.360 
Mean Post-Treatment MLD (mm) 1.64fio.19 2.21iO.29 <O.OOl’ 
‘p value remained significant (~0.05) after multivariate analysis 
Conclusion: Ostial location of the target lesion and smaller post-treatment MLD were 
predictors of subsequent death, MI and TVR following therapy with Sr-90 for ISR. Maxi- 
mizing final procedural results especially in ostial lesions may further improve outcomes 
after IRT. 
1077-2 Comparative Efficacy of Gamma-irradiation for 
Treatment of in-Stent Restenosis in Saphenous Vein 
Graft Versus Native Coronary Artery In-Stent 
Restenosis: An intravascular Ultrasound Study 
B, Gary S. Mint& Javed M. Ahmed, Neil J. Weissman, Akiko Maehara, 
Andrew E. Ajani. Lowell F. Satler, William 0. Suddath, Kenneth M. Kent, August0 D. 
Pichard. Ron Waksman, Washington Hospifal Center, Washington, Disf. of Columbia, 
Cardiovascular Reasearch Foundation, New York, New York. 
Background: We used serial (post irradiation and follow-up) volumetric intravascular 
ultrasound (IVUS) to compare the effectiveness of gamma-irradiation (‘g*lr) in saphen- 
ous vein graft (SVG) versus native coronary artery in-stent restenosis (ISR) lesions. 
Methods and Results: 47 patients with native coronary artery ISR from WRIST and 31 
patients with SVG ISR (12 from the WRIST and 19 from SVGWRIST) were compared. 
Post-irradiation and at B-month follow-up, stent, lumen, intimal hyperplasia (IH= stem 
minus lumen) areas were measured every lmm. ISR length was similar in the two 
groups (29+12 vs 29a14mm. p=O.9). Post-intervention measurements of stent (260+154 
vs 324*270mm’, p=O.4), lumen (164*91 vs 214*172mm3, p=O.3), and IH (96+77 vs 
109+119mms, p=O.5) volumes were similar in the two groups. The post-intervention min- 
imum lumen area (MLA) tended to be smaller in native artery ISR lesions (4.7~1.7 vs 
5.4*1.6mm2, p=O.il). Serial measurements are shown in the table. During follow-up, 
there was a slight increase in IH volume in native artery ISR lesions and a slight 
decrease in IH volume in SVG ISR lesions. There was a1so.a slight decrease in MLA in 
the native artery ISR lesions versus a slight increase in MLA in the SVG ISR lesions. As 
a result, the follow-up MLA in native artery lesions was smaller than in SVG ISR lesions 
(4.1e2.1 mm* versus 5.6i2.2 mm*, p=O.O067). 
Conclusion: Volumetric IVUS analysis shows that ‘921r brachytherapy appears to be as 
effective in SVG’s as it is in native artery ISR lesions. 
Changes In IVUS measurements 
Stent volume, mm3 
Lumen volume, mm3 
IH volume, mm3 
Minimum lumen area, mm’ 
Native SVG P 
-5*14 -9*30 0.4 
-14+41 -0*35 0.16 
9+3l3 -9*32 0.0463 
-0.6+1.7 0.2+1 .l 0.0067 
1077-3 Changing Pattern of in-Stent Restenosis After 
intracoronary Beta-irradiation: Downsizing the Lesion 
Christooh K. Naber, Chatchawan Suphatheeratham. Katja Brauck, Tom Oberheiden, 
Holger Eggebrecht, Yasser Abdel Rahman. Wolfgang Sauerwein, Raimund Erbel, 
Dietrich Baumgart, Cardiology, University of Essen, Essen, Germany 
Background: the treatment of diffuse recurrent stenosis after stent placement, remains a 
challenging task for the interventional cardiologist. lntracoronary radiation therapy (IRT) 
has proven to be highly effective in this indication. Nevertheless, also this novel therapy 
fails to prevent recurrent stenosis in a certain number of patients. It has been speculated, 
whether IRT may help in these cases to change the pattern of recurrent stenosis towards 
shorter and less diffuse lesions which are more suitable for the treatment with conven- 
tional interventional techniques. 
Methods and Results: 105 consecutive patients who underwent PTCA and adjuvant IRT 
for in-stent restenosis were included. Mean age was 56.1i12.2 years, 14.2% were dia- 
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betics and mean lesion length was 25.3i12.1 mm. Mean radiation dose was 21.5ti.3 
Gy. According to the Mehran classification of in-stent restenosis only 4.73b represented 
focal lesions -10 mm of length (class I), 69.5% were diffuse lesions (class II to Ill), and 
4.6% of the vesaeis were totally occluded (class IV). After 6 months all patients under- 
went angiographicfollow up (AFU). Binary restenosis was observed in 21 (20%) patients. 
Analysis of the length of the remaining lesion in all patients yielded a significantly shorter 
lesion length at AFU. In those 20 patients with significant restenosis lesion length was 
also significantly reduced from 35.3e15.7 mm to 10.9A5.1 mm (p<O.Ol). In addition we 
observed a significant downgrading of the remaining lesions towards less diffuse and 
more focal lesions (class I63.6%, class 11-111 6.7%, class IV 4.7%; p<O.Ol). 
Conclusion: IRT is a safe and effective tool for the treatment of diffuse in-stent resteno- 
sis. even in those cases with an apparent treatment failure, IRT leads to a shift in the pat- 
tern of recurrent stenosis towards a less diffuse and more focal stenosis which may be 
more suitable for the treatment with conventional interventional techniques. 
1077-4 Effects of Geographic Miss During lntracoronary 
Brachytherapy on Edge Stenosis at Follow-Up 
Rgn~@&, Ralner Schmid, Paul Wexberg, Christian Kirfsits. Stefan Denk, Gilbeti 
Beran, Peter Siostrzonek, Michael Gottsauner-Wolf, Irene Lang, Boris Pokrajac, Richard 
Poetter, Dietmar Glogar, Vienna University Hospital, Vienna, Austria. 
Background: Previous studies have described intracoronary brachytherapy (ICE) to be 
an effective strategy for the reduction of instent restenosis. However, the occurrence of 
edge stenosis after ICB is still a limitation. A possible explanation might be by an insuffi- 
cient irradiation of injured segments. This study aims to determine the effects of insuffi- 
cient irradiation of injured segments during ICE on angiographic outcome at follow up 
(FUP). 
Definition: Reference lsodose (RI): >90% of reference dose at lmm vessel wall depth; no 
gecgraphic miss (NGM): complete injured segment covered by RI; partial geographic 
miss (PGM): outmost 4mm of injured segment only partially covered by RI; geographic 
miss (GM): outmost 4mm not covered by RI. 
Methods: Baseline angiograms of patients with instent restenosis undergoing coronary 
reintervention followed by ICB were analyzed. The distances between outmost reinter- 
ventional injury and outmost RI were measured. The median length of all misses (GM 
and PGM) was 4mm. Accordingly, FUP analysis (minimal lumen diameter [MLD] and per- 
cent diameter stenosis [DS]) was performed at the outmost 4mm segment within the 
injured segment in group NGM. In case of outmost RI shorter than the outmost injury 
(GM or PGM), analysis was perfoned at the segment between outmost RI and outmost 
injury, however at a segment of at least 4mm. 
Resui?s: Edge analysis was performed at 216 edges of 109 patients. FUP was available 
for 116 edges (FUP period: 6.9t2.3 months). 66 edges were irradiated with a beta source 
and 26 edges with a gamma source. GM was found at 16 (13.6%) edges, and PGM at 10 
(6.6%) edges. FUP-MLD was 2.0+0.6, 1.6iO.7 and 1.4*0.7mm (p=O.O2) in the groups 
NGM. PGM, GM, and FUP-DS 23.5t24.9, 33.6k19.5 and 40.0*27.4% (p=O.O3) respec- 
tively. Posthoc Bonferroni analysis revealed significant differences between NGM and 
GM for both FUP-MLD (p=O.O2) and FUP-DS (p=O.O4). 
Conclusion: Geographic miss and partial geographic miss are associated with a smaller 
minimal lumen diameter and a higher percent diameter stenosis at follow up at the site of 
the insufficient radiation. This effect was more pronounced in the GM-patient cohort. 
1077-5 Effects of Debulking Before lntracoronary Beta- 
Radiation Therapy for Diffuse In-Stent Restenosis 
Seono_Woolc, Myeong-Ki Hong, Dae Hyuk Moon, Seung Jun Oh, Cheol Whan Lee, 
Jae-Joong Kim, Seung-Jung Park, Asan Medical Center. University of Ulsan, Seoul, 
South Korea. 
Background: The role of debulking before P-radiation therapy (RT) remains to be eluci- 
dated. We evaluated the clinical and angiographic outcomes after b-RT in patients (pts) 
with diffuse in-stent restenosis (ISR), with or without rotational atherectomy before irradi- 
ation. 
Methods: Fii consecutive pts were treated with ‘ssRe.MAGs-filled balloon after rota- 
tional atherectomy and adjunctive balloon angioplasty (phase I). Another 50 consecutive 
pts were treated without prior atherectomy (phase II). The prescribed dose was 150~ at 
1 mm deep into the tissue form balloon-artery interface. 
Results: Baseline clinical characteristics were not different between 2 groups. Prelimi- 
nary clinical and angiographic results were significantly better in pts with prior debulking 
before p-RT. Final results will be presented. 
Conclusion: These results suggest that debulking before RT with ‘ssRe-MAGs-filled bal- 
loon might improve the long-term clinical and angiographic outcomes in pts with diffuse 
ISR. 
Mean lesion length (mm) 
Mean radiation length (mm) 
Distal reference diameter (mm) 
Baseline MLD (mm) 
Final MLD (mm) 
6 months F/U MLD (mm) 
Loss index 
Restenosis rate 
Death or Ml 
Repeat revascularization 
Debulking + RT RT without debulking Pvalue 
(n=50) (n=50) 
25.3 + 12.7 22.9 * 6.6 0.007 
37.6 * 11.2 41.2f10.3 NS 
2.89 * 0.40 2.77 f 0.46 0.157 
0.60 zt 0.44 0.71 f 0.37 0.170 
2.66 f 0.39 2.61 f 0.44 0.363 
2.31 f 0.60 1.61 f 0.92 0.001 
0.17 f 0.31 0.41 * 0.57 0.001 
5/50 (10%) 14/33 (42%) 0.001 
0 0 
1 (2%) 6 (11%) 0.060 
1077-23 Predictors and Prognostic Values of CK-MB Cardiac 
Enzyme Elevation After Coronary Intervention With 
Radiation Treatment in InStent Restenosis 
m, G. Dangas. R. Mehran, A. A. Lansky, G. W. Stone, N. Kipshidze. 
M. Astatkie, M. Hawkey, D. Ashby, M. Mohamed, I. Moussa, M. B. Collins, J. W. Moses, 
M. 8. Leon, Cardiovascular Research Foundation. New York, New York, Lenox Hi// Heart 
& Vascular hsfitute, New York, New York. 
Background: Elevation of serum creatinine kinase-MB (CK-MB) afler percutaneous core- 
nary intervention (PCI) has been associated with increased mortality. We evaluated the 
predictors and prognostic values of CK-MB enzyme elevation after PCI plus radiation for 
in-stent restenosis. 
Methods: All 350 patients who were randomized to gamma-radiation (k-192) treatment 
after successful PCI in the WRIST, GAMMA-I, GAMMA-II and SCRIPP-III were included 
for the analysis. Patients were divided into 3 groups: CK-MB 23 times normal (N=61), 
CK-MB ~3 times normal (N=53). and no CK-MB elevation (N=236). 
Result: Baseline clinical characteristics were similar among the groups except for diabe- 
tes (Table). 
Conclusion: Post-procedural CK-MB elevation after radiation correlates with diabetes, 
long lesion length and long seed length of radiation source. CK-MB elevation is associ- 
ated with higher in-hospital complications and trend toward higher late thrombosis at 6 
months follow-up. 
CK-MB >3 CK-MB c3 No CK-MB P-Value 
times (n=61) times(n=53) Elevation(n=236) 
Diabetes (%) 42.6% 49.1% 30.0% 0.01 
Ref. vessel diameter (mm) 2.6 f 0.5 2.7 zt 0.3 2.7 * 0.5 0.6 
Lesion length (mm) 32.4 f 19.4 21.7 * 15.4 25.5 * 12.7 0.0013 
Seed length (mm) 55.2 + 17.2 47.4 * 17.6 45.2 + 13.9 <O.OOQl 
Final MLD (mm) 2.1 * 0.5 2.3 f 0.4 2.1 * 0.5 0.01 
Atheroablation (%) 26.7% 26.4% 35.4% 0.2 
In-hospital MACE (%) 31 .O% 6.1% 16.2% 0.02 
MACE at 6 months (%) 26.6% 26.9% 19.3% 0.1 
TVR at 6 months (‘%) 13.6% 25.0% 17.6% 0.2 
Death at 6 months (%) 1.7% 3.9% 1.7% 0.5 
Late thrombosis (%) 6.6% 2.0% 1.7% 0.09 
1077-24 lntracoronary Brachytherapy for In-Stent Restenosis: 
Eliminating the Side Branches? 
oohK Naber I Murad Al-Kahni, Katja Brauck. Tom Oberheiden. Holger Eggebrecht, 
Yasser Abdel Rahman, Wolfgang Sauerwein, Raimund Erbel, Dietrich Baumgart, 
Cardio/ogv University of Essen, Essen, Gemany. 
Background: lntracoronaly radiation therapy (IRT) has proven to be highly effective for 
the prevention of recurrent stenosis after percutaneous intervention of in-stent resteno- 
sis. Nevertheless, while the longitudinal dose fall-off in combination with tissue injury may 
increase the restenosis rate in the main vessel, the lateral dose fall-off may especially 
affect sidebranches of the treated vessel. This phenomenon appears not to take place in 
major sidebranches, but has been so far not investigated for small branches which may 
be more likely affected and may then result in a rarefication of the coronary system. 
Methods and Results: 66 consecutive patients who underwent PTCA and adjuvant IRT 
for in-stent restenosis were included. Mean age was 56.1*11.4 years, 13.1% were dia- 
betics and the mean lesion length was 27.3k15.1 mm. Mean radiation dose was 
21.5k2.2 Gy. In these patients all visible sidebranches in the irradiated segment +lOmm 
were analysed visually for patency and ostial stenosis immediately after the intervention 
and at the 6 months angiographic follow up. A range of 3 to 6 sidebranches was analy- 
sed per patient. After 6 months one vessel with a prior very diffuse lesion was totally 
occluded. In the other cases none of the sidebranches in the analysis were affected or 
even showed a significant narrowing in the proximal part. 
Conclusion: The present data do not support the hypothesis that in sidebranches of the 
treated vessel the combination of tissue injury together with the radiation dose fall-off 
leads to deleterious effects that result finally in a rarefication of the coronary vascular 
system. This finding underlines that IRT is a safe and effective tool for the treatment of in- 
stent restenosis. 
1077-25 lntracoronary Ultrasound Assessment of Intermediate 
Coronary Lesions: Comparison With Pressure-Derived 
Fractional Flow Reserve 
Jacek, Darius2 Dudek, Krzysztof Zmudka, Jacek S. Dubiel, JagMonian 
University, Krakow, Poland. 
Background: The criteria for the severity of stenosis in intracoronary ultrasound (ICUS) 
have not been objectively defined. However, ICUS-derived minimal luminal cross-sec- 
tional area (LAmin,mm’) a4.0 is widely used as the cut-off value for deferral percutane- 
ous coronary intervention in patient with intermediate coronary lesion (IML). Pressure- 
derived fractional flow reserve (FFR) co.75 is strongly related to inducible myocardial 
ischemia. The aim of the study was to evaluate the usefulness of ICUS assessment of 
IML in comparison to FFR. Methods: In 56 patients (pts) with IML (Diameter stenosis 
(DS) =40-60% by QCA) FFR was calculated after intrecoronary injection of adenosine 
(40.6Opg for the left coronary artery, 15-30pg for the right). Than, in all lesions ICUS was 
performed using automated pull-back (0.5mmlsec) to calculate LAmin and the lesion 
length (LL,mm). According to FFR pts were divided into two groups: Group 1: FFRi0.75 
